Alzheimer DiseaseE3DNCT06824142
Feasibility and Interest of the 3D Ephemeris for Temporal Orientation in Alzheimer's: Pilot Study
An observational study of Alzheimer Disease, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
In geriatric care, occupational therapists use validated tools to assess abilities and performance, identifying deficiencies and proposing rehabilitation programs. Temporal orientation disorders are common, with studies showing that individuals who make mistakes in identifying time are at higher risk of dementia. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Alzheimer Disease
- What is being tested?
- Evaluate in real-life conditions the effectiveness of an adapted external aid as a tool to support temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias in
- How many people
- 20 participants
- Where
- 1 siteFrance
- Study dates
- 25 Apr 2025to 30 Mar 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: ndividuals hospitalized in a geriatric rehabilitation and follow-up care service.
Who may be able to join
- Patient ≥ 65 years old.
- Patient presenting with temporal orientation impairment during the MMSE test.
- Patient with an MMSE score above 20 (mild stage) or a score between 10 and 20 (moderate stage).
- Patient who has not expressed any objection.
Who cannot join
- Presence of one or more disruptive behavioral disorders.
- Presence of confusion of unknown origin.
- Visual blindness.
- Inability to read or understand French.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Hôpital Georges Clemenceau
Champcueil, 91750
REBOURS Gwénaëlle, Occupational therapist, +331 69 23 21 33, gwenaelle.rebours@aphp.fr
About this study
Official title: Evaluation of the Feasibility, Practicality, and Interest of the 3D Ephemeris, a Tool for the Rehabilitation of Temporal Orientation Disorder in People With Alzheimer's Disease or Related Dementia: Monocentric Observational Pilot Study
In geriatric care, occupational therapists use validated tools to assess abilities and performance, identifying deficiencies and proposing rehabilitation programs. Temporal orientation disorders are common, with studies showing that individuals who make mistakes in identifying time are at higher risk of dementia. Temporal orientation issues typically precede spatial orientation problems in Alzheimer's, especially in hospital settings where environmental cues are lost. Maintaining temporal orientation during hospitalization is crucial. While no effective rehabilitation tool currently exists, a new prototype has been developed to address temporal orientation disorders in Alzheimer's and dementia patients, with plans for further evaluation.
Main Objective Evaluate in real-life conditions the effectiveness of an adapted external aid, such as the Ephéméride 3D tool, in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages.
Read more
Secondary Objectives
Assess the feasibility of establishing a routine with hospitalized patients. Gather feedback from patients, their families, and healthcare professionals regarding the external aid (usefulness, practicality, and aesthetics) as a prototype.
Evaluate the desire to continue using the tool once patients return home. Count the number of ephémérides deemed appropriate based on positive feedback from patients, families, and healthcare professionals. This figure is valuable for the company that may decide to scale up the product development. It will be calculated from the results of the attached questionnaires.
Method
This is a monocentric pilot observational study with data collection based on the following steps:
Day 5 (D5): Initial MMSE by the patient's physician. Prescription of temporal rehabilitation.
Day 6 (D6): Obtaining consent from the patient and their caregiver. Days 6 to 10 (D6 to D10): Daily assessment of the patient's knowledge of the season, year, month, day of the month (date), and day of the week without external aid (E3D).
Days 11 to 15 (D11 to D15): Daily assessment with external aid (E3D) for the same temporal knowledge.
Day 16 (D16): Interim and partial MMSE by the patient's physician. Days 17 to 21 (D17 to D21): Daily assessment without external aid (E3D). Days 22 to 26 (D22 to D26): Daily assessment with external aid (E3D). Day 27 (D27): Final and complete MMSE by the patient's physician. Days 28 to 30 (D28 to D30): Questionnaires for the patient, their caregiver, and healthcare professionals (including the study referent in the hospital).
20 patients will be included over a 1-year and 30-day period. Descriptive statistical analyses will be conducted to document patient characteristics at admission and the evolution of key parameters over time (D0 to D30). Paired statistical tests (T-tests/Chi-square) will be performed to identify significant changes between visit times. Longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating differences based on the use of external aids.
Conclusion This observational study primarily aims to describe the feasibility and benefits of using the Ephéméride 3D tool to support temporal orientation rehabilitation in individuals with mild to moderate dementia.
Read the detailed description
Context and Purpose In geriatric care, especially for individuals with Alzheimer's disease or other dementias, maintaining orientation in time (temporal orientation) is a critical aspect of cognitive function. Occupational therapists, using validated tools, help assess a patient's abilities and performance to identify deficiencies and propose rehabilitation programs tailored to the individual. Temporal orientation disorders, in which individuals struggle with identifying or understanding time (such as the day of the week, month, or year), are common in patients with Alzheimer's disease and related dementias. Research shows that individuals who make errors in temporal orientation-such as misidentifying the day, date, or month-are at a higher risk for developing dementia. Furthermore, temporal orientation issues often precede spatial orientation problems in Alzheimer's patients, meaning they can serve as early indicators of cognitive decline.
In hospital settings, these issues are often worsened due to the loss of personal environmental cues, which can leave patients feeling disoriented and confused. As such, maintaining temporal orientation during hospitalization is essential to reduce distress and support cognitive function. However, despite the clear importance of addressing temporal orientation in dementia care, there is currently no effective tool specifically designed to rehabilitate these deficits. This gap in care has prompted the development of a new tool, the Ephéméride 3D, a prototype external aid aimed at improving temporal orientation in individuals with mild to moderate dementia.
Main Objective The primary goal of this study is to evaluate, in real-life hospital conditions, the effectiveness of the Ephéméride 3D tool in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias. Specifically, the study focuses on patients in the mild to moderate stages of the disease, where early intervention could be most beneficial.
Secondary Objectives
In addition to evaluating the tool's effectiveness, the study includes several secondary objectives:
Feasibility of Routine Establishment: The study will assess the practicality of integrating the Ephéméride 3D tool into the daily routine of hospitalized patients. This includes evaluating whether the tool can be consistently used throughout a patient's hospitalization period.
Feedback Collection: Patients, their families, and healthcare professionals will provide feedback on the usefulness, practicality, and aesthetic appeal of the Ephéméride 3D tool. This feedback will be critical for determining whether the tool meets the needs of the patients it is designed to assist.
Desire for Continued Use: The study will also investigate whether patients would be willing to continue using the tool once they are discharged from the hospital and return home. This will help gauge the long-term potential of the tool for continuous cognitive support.
Evaluation of Positive Feedback: The study will track the number of Ephémérides deemed appropriate for wider use, based on positive feedback from patients, their families, and healthcare professionals. This feedback will be used to decide whether the product should be scaled for broader development and distribution. A key metric for this evaluation will be derived from the results of questionnaires filled out by patients, their caregivers, and healthcare providers.
Methodology This study is a monocentric pilot observational study, meaning it will be conducted at a single site and will involve direct observations of patients over a defined period. The data collection process will follow a series of structured steps, including assessments of the patients' temporal knowledge at various points during the study.
Study Timeline and Procedures:
Day 5 (D5): The patient's physician will conduct an initial Mini-Mental State Examination (MMSE) to assess cognitive function and prescribe temporal orientation rehabilitation as needed.
Day 6 (D6): Consent will be obtained from both the patient and their caregiver to participate in the study.
Days 6 to 10 (D6 to D10): The patient's knowledge of time (season, year, month, day, and day of the week) will be assessed daily without the Ephéméride 3D tool, to establish a baseline for comparison.
Days 11 to 15 (D11 to D15): The patient's temporal knowledge will be assessed daily with the Ephéméride 3D tool. This period will allow the researchers to observe whether the tool has any positive impact on the patient's ability to maintain temporal orientation.
Day 16 (D16): The patient's physician will conduct an interim MMSE to measure any changes in cognitive function from the baseline.
Days 17 to 21 (D17 to D21): A second round of daily assessments will take place without the Ephéméride 3D tool to observe any reversion in the temporal orientation without external support.
Days 22 to 26 (D22 to D26): Another round of daily assessments with the Ephéméride 3D tool will take place to examine the sustained impact of the tool on temporal orientation.
Day 27 (D27): A final MMSE will be conducted to evaluate any long-term changes in cognitive function resulting from the intervention.
Days 28 to 30 (D28 to D30): Questionnaires will be completed by the patient, their caregiver, and healthcare professionals (including the study referent in the hospital) to gather their opinions on the usefulness and effectiveness of the tool.
Study Population The study will include 20 patients over the course of 1 year and 30 days, providing sufficient data for statistical analysis.
Data Analysis The analysis will involve descriptive statistics to document patient characteristics at admission and track changes over time. Statistical tests such as paired T-tests and Chi-square tests will be used to identify significant changes in temporal orientation across assessment periods. Additionally, longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating the impact of the Ephéméride 3D tool on temporal orientation.
Expected Outcomes and Conclusion This observational study aims to determine whether the Ephéméride 3D tool can effectively support temporal orientation rehabilitation in individuals with Alzheimer's disease and related dementias. The study will primarily focus on the feasibility of using the tool in a hospital setting and the effectiveness of improving temporal orientation. If the tool proves successful, it could provide a practical solution for addressing temporal orientation deficits, thereby improving the overall quality of life for individuals with cognitive impairments.
The feedback gathered from patients, families, and healthcare providers will be essential in refining the tool and determining whether it is suitable for widespread use. Ultimately, the study will lay the foundation for future development and potential scaling of the Ephéméride 3D tool, with the hope of improving cognitive rehabilitation practices for individuals suffering from Alzheimer's disease and other dementias.
- Conditions
- Alzheimer Disease
- Being tested
- Evaluate in real-life conditions the effectiveness of an adapted external aid as a tool to support temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias in
- Keywords
- Alzheimer's disease, Related dementia, Temporal disorientation, Rehabilitation, Adapted external aid
- Medical subject headings
- Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Evaluate in real-life conditions the effectiveness of an adapted external aid as a tool to support temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias inOther
Unlike other interventions, the E3D tool combines an intuitive, user-friendly interface with real-time temporal cues, offering a personalized experience designed to improve cognitive engagement. This external aid is aimed at fostering independence and improving daily functioning by providing clear and consistent information on time-related aspects, such as season, month, day of the week, and current date.
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of Temporal Orientation Rehabilitation with the Ephéméride 3D Tool
This outcome measure assesses the effectiveness of the Ephéméride 3D tool in improving temporal orientation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages. It is based on daily assessments of the patient's knowledge of time-related information, including season, year, month, day of the month (date), and day of the week, both with and without the use of the external aid (E3D)
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2025
- Study start25 Apr 2025
- Primary completion30 Mar 2026 (estimated)
- Study completion30 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alzheimer DiseaseStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06824142
- Sponsor's protocol ID
- APHP240896
- Acronym
- E3D
- Status last verified
- Jan 2026
- First submitted
- 7 Feb 2025
- Last updated
- 15 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION
Study at a glance
From the registry record, last updated by the sponsor on 15 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Feasibility, Practicality, and Interest of the 3D Ephemeris, a Tool for the Rehabilitation of Temporal Orientation Disorder in People With Alzheimer's Disease or Related Dementia: Monocentric Observational Pilot Study
- ClinicalTrials.gov ID
- NCT06824142
- Acronym / sponsor ID
- E3D / APHP240896
- Conditions
- Alzheimer Disease
- Keywords
- Alzheimer's disease, Related dementia, Temporal disorientation, Rehabilitation, Adapted external aid
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Study start
- 25 Apr 2025 (actual)
- Primary completion
- 30 Mar 2026 (estimated)
- Study completion
- 30 Mar 2026 (estimated)
- First posted
- 13 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In geriatric care, occupational therapists use validated tools to assess abilities and performance, identifying deficiencies and proposing rehabilitation programs. Temporal orientation disorders are common, with studies showing that individuals who make mistakes in identifying time are at higher risk of dementia. Temporal orientation issues typically precede spatial orientation problems in Alzheimer's, especially in hospital settings where environmental cues are lost. Maintaining temporal orientation during hospitalization is crucial. While no effective rehabilitation tool currently exists, a new prototype has been developed to address temporal orientation disorders in Alzheimer's and dementia patients, with plans for further evaluation.
Main Objective Evaluate in real-life conditions the effectiveness of an adapted external aid, such as the Ephéméride 3D tool, in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages.
Secondary Objectives
Assess the feasibility of establishing a routine with hospitalized patients. Gather feedback from patients, their families, and healthcare professionals regarding the external aid (usefulness, practicality, and aesthetics) as a prototype.
Evaluate the desire to continue using the tool once patients return home. Count the number of ephémérides deemed appropriate based on positive feedback from patients, families, and healthcare professionals. This figure is valuable for the company that may decide to scale up the product development. It will be calculated from the results of the attached questionnaires.
Method
This is a monocentric pilot observational study with data collection based on the following steps:
Day 5 (D5): Initial MMSE by the patient's physician. Prescription of temporal rehabilitation.
Day 6 (D6): Obtaining consent from the patient and their caregiver. Days 6 to 10 (D6 to D10): Daily assessment of the patient's knowledge of the season, year, month, day of the month (date), and day of the week without external aid (E3D).
Days 11 to 15 (D11 to D15): Daily assessment with external aid (E3D) for the same temporal knowledge.
Day 16 (D16): Interim and partial MMSE by the patient's physician. Days 17 to 21 (D17 to D21): Daily assessment without external aid (E3D). Days 22 to 26 (D22 to D26): Daily assessment with external aid (E3D). Day 27 (D27): Final and complete MMSE by the patient's physician. Days 28 to 30 (D28 to D30): Questionnaires for the patient, their caregiver, and healthcare professionals (including the study referent in the hospital).
20 patients will be included over a 1-year and 30-day period. Descriptive statistical analyses will be conducted to document patient characteristics at admission and the evolution of key parameters over time (D0 to D30). Paired statistical tests (T-tests/Chi-square) will be performed to identify significant changes between visit times. Longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating differences based on the use of external aids.
Conclusion This observational study primarily aims to describe the feasibility and benefits of using the Ephéméride 3D tool to support temporal orientation rehabilitation in individuals with mild to moderate dementia.
Detailed description
Context and Purpose In geriatric care, especially for individuals with Alzheimer's disease or other dementias, maintaining orientation in time (temporal orientation) is a critical aspect of cognitive function. Occupational therapists, using validated tools, help assess a patient's abilities and performance to identify deficiencies and propose rehabilitation programs tailored to the individual. Temporal orientation disorders, in which individuals struggle with identifying or understanding time (such as the day of the week, month, or year), are common in patients with Alzheimer's disease and related dementias. Research shows that individuals who make errors in temporal orientation-such as misidentifying the day, date, or month-are at a higher risk for developing dementia. Furthermore, temporal orientation issues often precede spatial orientation problems in Alzheimer's patients, meaning they can serve as early indicators of cognitive decline.
In hospital settings, these issues are often worsened due to the loss of personal environmental cues, which can leave patients feeling disoriented and confused. As such, maintaining temporal orientation during hospitalization is essential to reduce distress and support cognitive function. However, despite the clear importance of addressing temporal orientation in dementia care, there is currently no effective tool specifically designed to rehabilitate these deficits. This gap in care has prompted the development of a new tool, the Ephéméride 3D, a prototype external aid aimed at improving temporal orientation in individuals with mild to moderate dementia.
Main Objective The primary goal of this study is to evaluate, in real-life hospital conditions, the effectiveness of the Ephéméride 3D tool in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias. Specifically, the study focuses on patients in the mild to moderate stages of the disease, where early intervention could be most beneficial.
Secondary Objectives
In addition to evaluating the tool's effectiveness, the study includes several secondary objectives:
Feasibility of Routine Establishment: The study will assess the practicality of integrating the Ephéméride 3D tool into the daily routine of hospitalized patients. This includes evaluating whether the tool can be consistently used throughout a patient's hospitalization period.
Feedback Collection: Patients, their families, and healthcare professionals will provide feedback on the usefulness, practicality, and aesthetic appeal of the Ephéméride 3D tool. This feedback will be critical for determining whether the tool meets the needs of the patients it is designed to assist.
Desire for Continued Use: The study will also investigate whether patients would be willing to continue using the tool once they are discharged from the hospital and return home. This will help gauge the long-term potential of the tool for continuous cognitive support.
Evaluation of Positive Feedback: The study will track the number of Ephémérides deemed appropriate for wider use, based on positive feedback from patients, their families, and healthcare professionals. This feedback will be used to decide whether the product should be scaled for broader development and distribution. A key metric for this evaluation will be derived from the results of questionnaires filled out by patients, their caregivers, and healthcare providers.
Methodology This study is a monocentric pilot observational study, meaning it will be conducted at a single site and will involve direct observations of patients over a defined period. The data collection process will follow a series of structured steps, including assessments of the patients' temporal knowledge at various points during the study.
Study Timeline and Procedures:
Day 5 (D5): The patient's physician will conduct an initial Mini-Mental State Examination (MMSE) to assess cognitive function and prescribe temporal orientation rehabilitation as needed.
Day 6 (D6): Consent will be obtained from both the patient and their caregiver to participate in the study.
Days 6 to 10 (D6 to D10): The patient's knowledge of time (season, year, month, day, and day of the week) will be assessed daily without the Ephéméride 3D tool, to establish a baseline for comparison.
Days 11 to 15 (D11 to D15): The patient's temporal knowledge will be assessed daily with the Ephéméride 3D tool. This period will allow the researchers to observe whether the tool has any positive impact on the patient's ability to maintain temporal orientation.
Day 16 (D16): The patient's physician will conduct an interim MMSE to measure any changes in cognitive function from the baseline.
Days 17 to 21 (D17 to D21): A second round of daily assessments will take place without the Ephéméride 3D tool to observe any reversion in the temporal orientation without external support.
Days 22 to 26 (D22 to D26): Another round of daily assessments with the Ephéméride 3D tool will take place to examine the sustained impact of the tool on temporal orientation.
Day 27 (D27): A final MMSE will be conducted to evaluate any long-term changes in cognitive function resulting from the intervention.
Days 28 to 30 (D28 to D30): Questionnaires will be completed by the patient, their caregiver, and healthcare professionals (including the study referent in the hospital) to gather their opinions on the usefulness and effectiveness of the tool.
Study Population The study will include 20 patients over the course of 1 year and 30 days, providing sufficient data for statistical analysis.
Data Analysis The analysis will involve descriptive statistics to document patient characteristics at admission and track changes over time. Statistical tests such as paired T-tests and Chi-square tests will be used to identify significant changes in temporal orientation across assessment periods. Additionally, longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating the impact of the Ephéméride 3D tool on temporal orientation.
Expected Outcomes and Conclusion This observational study aims to determine whether the Ephéméride 3D tool can effectively support temporal orientation rehabilitation in individuals with Alzheimer's disease and related dementias. The study will primarily focus on the feasibility of using the tool in a hospital setting and the effectiveness of improving temporal orientation. If the tool proves successful, it could provide a practical solution for addressing temporal orientation deficits, thereby improving the overall quality of life for individuals with cognitive impairments.
The feedback gathered from patients, families, and healthcare providers will be essential in refining the tool and determining whether it is suitable for widespread use. Ultimately, the study will lay the foundation for future development and potential scaling of the Ephéméride 3D tool, with the hope of improving cognitive rehabilitation practices for individuals suffering from Alzheimer's disease and other dementias.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- ndividuals hospitalized in a geriatric rehabilitation and follow-up care service.
Key inclusion criteria (4 listed)
- Patient ≥ 65 years old.
- Patient presenting with temporal orientation impairment during the MMSE test.
- Patient with an MMSE score above 20 (mild stage) or a score between 10 and 20 (moderate stage).
- Patient who has not expressed any objection.
Key exclusion criteria (4 listed)
- Presence of one or more disruptive behavioral disorders.
- Presence of confusion of unknown origin.
- Visual blindness.
- Inability to read or understand French.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Evaluate in real-life conditions the effectiveness of an adapted external aid as a tool to support temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias inUnlike other interventions, the E3D tool combines an intuitive, user-friendly interface with real-time temporal cues, offering a personalized experience designed to improve cognitive engagement. This external aid is aimed at fostering independence and improving daily functioning by providing clear and consistent information on time-related aspects, such as season, month, day of the week, and current date. | Other | – |
Primary outcome
Evaluation of Temporal Orientation Rehabilitation with the Ephéméride 3D Tool
Time frame: 30 days
This outcome measure assesses the effectiveness of the Ephéméride 3D tool in improving temporal orientation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages. It is based on daily assessments of the patient's knowledge of time-related information, including season, year, month, day of the month (date), and day of the week, both with and without the use of the external aid (E3D)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jan 2026.
- Individual participant dataSharing planned: No. DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION
Related trials for Alzheimer Disease
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
RecruitingPhase 3
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Alzheimer's Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Alzheimer Disease, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact REBOURS Gwénaëlle, Occupational therapist (+331 69 23 21 33, gwenaelle.rebours@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of Temporal Orientation Rehabilitation with the Ephéméride 3D Tool (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.